SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-075248
Filing Date
2023-06-27
Accepted
2023-06-27 16:10:44
Documents
1
Period of Report
2023-06-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2319568-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2319568-1_3seq1.xml 3 3694
  Complete submission text file 0001104659-23-075248.txt   5680
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Issuer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SVEAVAGEN 17 18TH FLOOR STOCKHOLM V7 SE-11157
Business Address SVEAVAGEN 17 18TH FLOOR STOCKHOLM V7 SE-11157 46705142196
TRILL AB (Reporting) CIK: 0001887436 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36291 | Film No.: 231047391

Mailing Address C/O TRILL INVEST AB SVEAVAGEN 17 FL 18 STOCKHOLM V7 SE 111 57
Business Address
STAHLBERG JAN (Reporting) CIK: 0001983161 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36291 | Film No.: 231047392